Samsara BioCapital as of Dec. 31, 2025
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 21 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp (SRRK) | 31.3 | $304M | 6.9M | 44.05 | |
| Mineralys Therapeutics (MLYS) | 22.0 | $213M | 5.9M | 36.29 | |
| Kalaris Therapeutics (KLRS) | 11.3 | $109M | 13M | 8.44 | |
| Septerna (SEPN) | 9.1 | $88M | 3.1M | 27.88 | |
| Alumis (ALMS) | 5.8 | $56M | 5.8M | 9.76 | |
| Neurogene (NGNE) | 3.6 | $35M | 1.7M | 20.60 | |
| Inventiva Sa Ads (IVA) | 2.5 | $24M | 5.2M | 4.65 | |
| Gossamer Bio (GOSS) | 2.3 | $22M | 7.2M | 3.10 | |
| Upstream Bio (UPB) | 2.1 | $20M | 736k | 27.15 | |
| Aquestive Therapeutics (AQST) | 1.7 | $16M | 2.5M | 6.46 | |
| Jade Biosciences Com New (JBIO) | 1.5 | $15M | 969k | 15.43 | |
| Vtv Therapeutics Cl A New (VTVT) | 1.2 | $12M | 299k | 39.99 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 1.2 | $12M | 8.5M | 1.35 | |
| Palvella Therapeutics Inc Ne (PVLA) | 1.1 | $11M | 105k | 104.67 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.0 | $10M | 75k | 134.85 | |
| X4 Pharmaceuticals Com New (XFOR) | 0.8 | $7.8M | 2.0M | 4.00 | |
| Nkarta (NKTX) | 0.7 | $6.5M | 3.5M | 1.85 | |
| Arcellx Common Stock (ACLX) | 0.4 | $4.0M | 61k | 65.20 | |
| Sutro Biopharma Com Shs (STRO) | 0.2 | $2.4M | 205k | 11.57 | |
| Contineum Therapeutics Cl A (CTNM) | 0.1 | $826k | 72k | 11.43 | |
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.0 | $41k | 124k | 0.33 |
